Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Guinea-Bissau's coup called a 'sham' by West African political figures - 2Ethiopian earthquakes and volcanic eruptions: earth scientist explains the link
- 3A definitive Manual for Internet Mastering and Expertise Improvement
- 4Experience Unrivaled Sound: Top Speakers You Really want to Hear
- 5It's time for Artemis II to break Apollo 13's distance record. What to know about the moon flyby
- The Force of Care: Living with Goal
- Israel says Iran's military industry will be destroyed 'within days'
- Amplifying Cash The executives: The Upsides and downsides of Various Ledgers
- Collection of 7,000-year-old ostrich eggs discovered under sand dunes in southern Israel
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- Stop the ‘good’ vs ‘bad’ snap judgments and watch your world become more interesting
- New research reveals urban raccoons across the US show early signs of domestication
- Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
- Experiences in Natural life Protection: Individual Progressives' Excursions
